St. Petersburg Times - Vioxx, recalled in 2004 after being linked to heart attacks, had been taken by 80-million people. Trasylol has been administered to more than 4-million. “Bayer’s action is yet another example, and an egregious one, that shows the lack of transparency Read More
Roanoke Times - The current regulatory […]

Roanoke Times - The current regulatory system failed everyone in the Merck Vioxx fiasco. Either that, or everyone failed the system. Merck rushed a drug to market before concerns about potential side effects could be fully explored. It then began a massive marketing Read More
CNBC - The new year could be […]

Timberjay Newspapers - Using Vioxx as an example of research based companies not being honest with healthcare providers is a weak argument and is unfair. We complete exhaustive research on our medications prior to their availability to the public. The Food and Drug Read More
Spokane Spokesman-Review - A 21-year-old University of […]

The Associated Press

Analysts Foresee More Boutique DrugsThe Associated Press - 10 hours agoThe FDA also flatly rejected Merck's arthritis drug Arcoxia, a follow-up to Vioxx, the best-selling pain medication pulled from the market in 2004 after …

Read More…

Forum: Senate must repeal immunity lawTraverse City Record Eagle, MI - Dec 29, 2007Cox and Richter took the painkiller […]

BREAKING: Challenge to Vioxx settlement withdrawnPoint of Law, NY - Dec 27, 2007The challenge to the Vioxx settlement made on ethical grounds (which got substantial publicity in the New York Times and Wall Street Journal when it was …

Read More…

Drug companies look to niche treatmentsBusinessWeek - 1 hour agoThe FDA also flatly rejected Merck's arthritis drug […]

Forum: Senate must repeal immunity lawTraverse City Record Eagle, MI - 18 hours agoCox and Richter took the painkiller Vioxx, while Hargrove took Celexa and prednisone. Unfortunately for these three people and thousands more like them, …

Read More…

BREAKING: Challenge to Vioxx settlement withdrawnPoint of Law, NY - Dec 27, 2007The challenge to the Vioxx settlement made on ethical […]

Raleigh News & Observer - According to GSK, clinical studies have not shown any significant behavioral issues with Relenza. The FDA has increasingly zeroed in on drug safety since the drug maker Merck pulled the painkiller Vioxx three years ago when a study suggested the Read More
Nashville Tennessean - In 2004, […]

PR Newswire - AMHERST, N.Y., Nov. 14 /PRNewswire/ — Counsel Financial Services (CFS), the nation’s largest provider of working capital credit lines exclusively to attorneys, announced today that it will provide loans to litigators representing Vioxx plaintiffs Read More
Reuters - It comes after criticism of a slow response in dealing with […]

KXAN - New York — The maker of the painkiller Vioxx has agreed to pay $4.85 billion to settle thousands of lawsuits over the drug. The announcement by Merck Friday covers more than 26,000 cases filed against it in federal and state courts. It becomes final Read More
BusinessWeek - So instead […]

Nalgene bottles may be harmfulphillyBurbs.com, PA - Dec 26, 2007“Quite an assurance from the same folks who let Vioxx on the market and the same administration that let toxic toys be imported into the country all year …

Read More…

BREAKING: Challenge to Vioxx settlement withdrawnPoint of Law, NY - Dec 27, 2007The challenge to the Vioxx settlement made on […]